Tag Archives: federal funding

Upcoming Panel will Highlight The Successes of The NCATS Tech Transfer Model

Capitol

On October 29, 2014 the Center for Clean Energy Innovation and the House Technology Transfer Caucus will be hosting a panel of experts to discuss NIH’s NCATS program and its impact on the tech transfer policy debate. One of the biggest challenges for federally funded research and technology is bridging the development “Valley of Death.” Despite their tremendous potential impact, many promising discoveries die during development due to their insufficient advancements, which detract private investment. Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Raising the Stakes in Biotech

JimGreenwood

Small biotech companies continue to struggle to obtain funding as capital markets remain tight. The S&P downgrade may create even tighter credit markets and raise the cost of available credit, for small and large companies. To the extent that the downgrade leads capital flows out of the U.S., that hurts biotech. Biotech’s contributions to the world are critically needed. Our industry holds great promise for curing and treating many prevalent diseases, such as Alzheimer’s, cancer, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Bayh Dole Act a failure?

By Guest Writer Joseph Allen One hotly debated topic in Washington of real importance to the biotechnology community is how well the annual multi-billion dollar federal investment in R&D is being translated into new products, jobs and companies needed to improve the lives of US taxpayers and help pull the US economy out of its current doldrums.  An interesting insight on the debate is captured in a Washington Post article “Innovation’s golden opportunity” that ran Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,